Navigation Links
Mature US and European coronary artery bypass graft device markets will Shrink through 2021
Date:7/11/2013

TORONTO, July 11, 2013 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, declines in isolated coronary artery bypass graft (CABG) procedures in the United States and Europe will primarily be attributed to the increasing use of percutaneous coronary intervention (PCI), which is less invasive and offers shorter recovery times. In particular, younger patients or patients with less severe coronary artery disease are increasingly being referred for PCIs.

(Logo: http://photos.prnewswire.com/prnh/20130103/MM36799LOGO)  

The average age of patients undergoing CABG procedures is therefore rising, and these patients are more likely to suffer from other heart-related diseases that will also require treatment. As a result, the proportion of CABG surgeries performed at the same time as other procedures, such as open surgical heart valve procedures or surgical ablations, will expand, which will help to sustain overall CABG procedure volumes through 2021.

In the US and Europe, there will be a slight increase in revenues for devices used in endoscopic vessel harvesting (EVH) because they are less invasive compared to traditional vessel harvesting techniques. There are minor differences, however, between the EVH device segments in the two regions. In the US, adoption of EVH devices is already close to saturation; therefore, the shift to premium-priced EVH devices will primarily drive the market.

"In Europe, there is still potential for EVH use to grow because in the past, physicians preferred less expensive traditional methods," said MRG Analyst Tony Su. "However, as patients and surgeons become increasingly aware of the clinical benefits of EVH devices, their use in CABG procedures will expand."

Nonetheless, price competition and budget constraints will continue to hinder the largely mature and commoditized CABG device markets in both regions. Major competitors such as Sorin Group, MAQUET, Medtronic and Terumo will be better positioned to compete in this challenging environment and will likely not be threatened by any new entrants.

Millennium Research Group's US Markets for Coronary Artery Bypass Graft Devices 2013 and European Markets for Coronary Artery Bypass Graft Devices 2013 reports include unit, procedure, average selling price and revenue information, along with market drivers and limiters and a competitive landscape for on-pump coronary artery bypass devices, off-pump coronary artery bypass devices, EVH devices and anastomosis assist devices in the United States, France, Germany, Italy, Spain and the United Kingdom. Supplemental country coverage is also available for Austria, Belgium, the Czech Republic, Denmark, Finland, Greece, Hungary, the Netherlands, Norway, Poland, Portugal, Romania, Sweden, Switzerland and Ukraine, as well as in aggregate for the rest of the European countries.

About Millennium Research Group
Millennium Research Group (www.MRG.net), a Decision Resources Group company (www.DecisionResourcesGroup.com), is the global authority on medical technology market intelligence and the leading provider of strategic information to the healthcare sector. The company provides specialized industry expertise through multiclient market research, ongoing Marketrack™ projects, customer loyalty tracking, facility-level procedure forecasting, and customized solutions.
About Decision Resources Group
Decision Resources Group is a cohesive portfolio of companies that offers best-in-class, high-value information, and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources Group at www.DecisionResourcesGroup.com.

All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.For more information, contact:Christopher Comfort
Decision Resources Group
781-993-2597
ccomfort@dresources.comAlex Jablokow
Millennium Research Group
617-599-8613
ajablokow@mrg.net 


'/>"/>
SOURCE Millennium Research Group
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Varying Technology and Application Trends Pep up the Mature Research Antibodies Market, Finds Frost & Sullivan
2. Revolutionary Device for Premature Ejaculation Treatment
3. Prolong TM, a New Revolutionary First Line Treatment for Premature Ejaculation is Licensed in Europe
4. Maximizing the Potential of Mature Brands with Key Lifecycle Management Strategies Tailored to the Pharmaceutical Industry
5. Absorption Pharmaceuticals to Receive Patent for Premature Ejaculation Topical Medication
6. Independent Pharmacy Cooperative to Distribute Promescent, Topical Medication for Premature Ejaculation
7. Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter
8. Biodels Intellectual Property Position Strengthened for Ultra-Rapid-Acting Insulin Programs by Notice of Intent to Grant from European Patent Office
9. Marken Acquires European Kit Building Operation From LabCorp Clinical Trials
10. Blood Disorders: European Hematologists Gather in Amsterdam, June 14-17, 2012
11. Mylan Launches Generic Lipitor® in Five European Countries
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: RO, ... clearance for its Elecsys BRAHMS PCT (procalcitonin) assay as ... or septic shock. With this clearance, Roche is the ... fully integrated solution for sepsis risk assessment and management. ... bacterial infection and PCT levels in blood can aid ...
(Date:6/23/2016)... , June 23, 2016 Research ... Pharma News Issue 52" report to their offering. ... in influenza treatment creates a favourable commercial environment for MedImmune ... growing patient base that will serve to drive considerable growth ... vaccine would serve to cap sales considerably, but development is ...
(Date:6/23/2016)... PARK RIDGE, Ill. and INDIANAPOLIS ... caliber of students receiving a Lilly Diabetes Tomorrow,s Leaders ... hands. The 2016 scholarship winners, announced today online at ... refused to let type 1 diabetes stand in the ... Lilly Diabetes has supported the Foundation,s scholarship program since ...
Breaking Medicine Technology:
(Date:6/26/2016)... Creek, Michigan (PRWEB) , ... June 26, 2016 , ... ... joined as sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table in ... in honor of the city’s history as home to some of the world’s leading ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... ... fertility once they have been diagnosed with endometriosis. These women need a treatment ... also require a comprehensive approach that can help for preservation of fertility and ...
(Date:6/25/2016)... ... ... "With 30 hand-drawn hand gesture animations, FCPX users can easily customize each ... Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures into hand ... select a ProHand generator and drag it above media or text in the Final ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... On Friday, ... presented a Bronze Wellness at Work award to iHire in recognition of their exemplary ... part of the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI ...
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort to ... treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain management ... (SCD) is a disorder of the red blood cells, which can cause episodes of ...
Breaking Medicine News(10 mins):